These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Comparing the bronchodilating effects of ipratropium bromide and theophylline]. Dai L; Li X; Yang Y Zhonghua Jie He He Hu Xi Za Zhi; 1998 Oct; 21(10):609-11. PubMed ID: 11477880 [TBL] [Abstract][Full Text] [Related]
26. Clinical study on carbuterol (SKF 40383), a new selective bronchodilator agent aerosol: double blind comparison with isoproterenol aerosol. Saleeby PR; Ziskind MM Curr Ther Res Clin Exp; 1975 Mar; 17(3):225-33. PubMed ID: 805017 [No Abstract] [Full Text] [Related]
27. Inhaled corticosteroids in COPD: the EUROSCOP study in perspective. Yernault JC Eur Respir J; 1992 Nov; 5(10):1169-70. PubMed ID: 1486959 [No Abstract] [Full Text] [Related]
28. Bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airway disease. Hahn DL N Engl J Med; 1993 Apr; 328(14):1044; author reply 1044-5. PubMed ID: 8450868 [No Abstract] [Full Text] [Related]
29. Should the FVC be considered in evaluating response to bronchodilator? Girard WM; Light RW Chest; 1983 Jul; 84(1):87-9. PubMed ID: 6861550 [No Abstract] [Full Text] [Related]
30. Factor analysis of changes in dyspnea and lung function parameters after bronchodilation in chronic obstructive pulmonary disease. Taube C; Lehnigk B; Paasch K; Kirsten DK; Jörres RA; Magnussen H Am J Respir Crit Care Med; 2000 Jul; 162(1):216-20. PubMed ID: 10903244 [TBL] [Abstract][Full Text] [Related]
31. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group. Maesen FP; Smeets JJ; Sledsens TJ; Wald FD; Cornelissen PJ Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576 [TBL] [Abstract][Full Text] [Related]
32. The volumetric response to bronchodilators in stable chronic obstructive pulmonary disease. Walker PP; Calverley PM COPD; 2008 Jun; 5(3):147-52. PubMed ID: 18568838 [TBL] [Abstract][Full Text] [Related]
33. [Comparative studies on the effectiveness of inhalant beta 2 mimetics therapy in patients with obstructive respiratory disorders]. Würtemberger G; Weil R; Schulte-Mönting J; Matthys H Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():304-6. PubMed ID: 2902608 [No Abstract] [Full Text] [Related]
35. Irreversible airflow obstruction. Evolution in asthma. Finucane KE; Greville HW; Brown PJ Med J Aust; 1985 May; 142(11):602-4. PubMed ID: 4000023 [TBL] [Abstract][Full Text] [Related]
36. [Acute effects of bronchodilators on lung function and dyspnea in COPD patients]. Taube C; Jörres RA; Magnussen H Pneumologie; 2000 Jun; 54(6):252-5. PubMed ID: 10934896 [No Abstract] [Full Text] [Related]
37. Response to bronchodilators. Shim C Clin Chest Med; 1989 Jun; 10(2):155-64. PubMed ID: 2567648 [TBL] [Abstract][Full Text] [Related]
38. Aerosol penetration into the lung; influence on airway responses. Dolovich M; Ryan G; Newhouse MT Chest; 1981 Dec; 80(6 Suppl):834-6. PubMed ID: 7307620 [No Abstract] [Full Text] [Related]
39. Bronchodilators and chronic obstructive pulmonary disease. Singh A N Z Med J; 1997 Aug; 110(1049):300. PubMed ID: 9293287 [No Abstract] [Full Text] [Related]
40. A comparison of six different ways of expressing the bronchodilating response in asthma and COPD; reproducibility and dependence of prebronchodilator FEV1. Dompeling E; van Schayck CP; Molema J; Akkermans R; Folgering H; van Grunsven PM; van Weel C Eur Respir J; 1992 Sep; 5(8):975-81. PubMed ID: 1426206 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]